Medical Oncologist
Paying for treatment
Will Insurance or a Government Scheme — Pay for Enzalutamide?
Enzalutamide is an oral tablet taken at home, which means the standard hospital-stay rules in most schemes do not automatically apply. Whether you can get it covered depends on which scheme you belong to and whether your treating hospital is registered with that scheme.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Oral drugs need a separate check — Enzalutamide is taken at home as tablets, not given by drip in hospital. Many schemes were designed around inpatient treatment and handle oral cancer drugs differently.
- Multiple routes exist — Government schemes, private insurance, and the manufacturer's patient support programme are three separate pathways. You may qualify for more than one.
- Scheme drug lists change — Which drugs each scheme covers is updated periodically. Always confirm directly with the scheme, not from information you read online months ago.
- The hospital social worker is your best first call — Most large cancer centres have a medical social worker trained to identify which schemes apply to your situation and what paperwork you need.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Enzalutamide is an oral medicine taken at home, which means most hospital-stay schemes do not cover it automatically. Whether PM-JAY, Aarogyasri, CGHS or your private policy pays depends on your eligibility category. The manufacturer also runs a patient assistance programme that is worth asking your oncologist about.
What do these scheme names mean?
- PM-JAY / Ayushman Bharat
- The national government health assurance scheme run by the Ministry of Health and Family Welfare. It covers families identified as among the bottom 40% of households by income. Coverage is for listed treatment packages at empanelled hospitals.
- Aarogyasri (Telangana)
- Telangana's state health scheme for below-poverty-line families. It covers specific medical procedures and treatments at hospitals registered with the scheme.
- YSR Aarogyasri (Andhra Pradesh)
- Andhra Pradesh's state scheme, accessible to households holding White or Pink ration cards. It covers a range of serious illnesses including cancer, with an enhanced ceiling for life-threatening conditions.
- CGHS
- Central Government Health Scheme. It covers serving and retired central government employees, their spouses, and dependent family members. Cancer medicines can be reimbursed with a prescription from a CGHS-recognised specialist.
- ECHS
- Ex-Servicemen Contributory Health Scheme. It covers retired defence personnel and their dependants. Specialist-prescribed cancer medicines can be claimed, similarly to CGHS.
- ESI
- Employee State Insurance. If your employer deducts ESI from your salary, you may have access to treatment and medicines through ESI hospitals. Coverage for specialist cancer drugs varies by state.
- Pre-authorisation
- Approval from the scheme before you start a treatment. Most government schemes require this for high-cost cancer drugs. Applying before you begin avoids the risk of the claim being rejected after you have already started.
- Patient assistance programme
- A support programme run by the drug manufacturer for patients who cannot afford the full cost of treatment. Eligibility is assessed on both income and clinical criteria. Your oncologist or hospital social worker can help you apply.
What should you check before your next appointment?
- Check whether you hold an Ayushman Bharat (PM-JAY) card — search the PM-JAY beneficiary portal using your Aadhaar number.
- If you are in Telangana, confirm whether your family has an Aarogyasri card linked to a White or Pink ration card.
- If you are in Andhra Pradesh, check your YSR Aarogyasri eligibility at your nearest government hospital or the scheme's official portal.
- If you are a central government employee, pensioner or dependent, ask your department or HR office about your CGHS coverage category.
- If you are an ex-serviceman or a dependent, contact your nearest ECHS polyclinic about coverage for cancer medicines.
- If your employer deducts ESI contributions, ask your HR department whether specialist cancer drug coverage applies in your case.
- If you have private health insurance, read your policy for the words 'oral chemotherapy', 'targeted therapy' or 'outpatient cancer drugs' — these are the clauses that determine coverage.
- Ask your treating oncologist or the hospital's medical social worker whether a manufacturer patient assistance programme is available and whether you qualify.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
How do the main schemes compare for enzalutamide?
| PM-JAY / Ayushman Bharat | Telangana Aarogyasri | AP YSR Aarogyasri | CGHS / ECHS | |
|---|---|---|---|---|
| Who qualifies | Families in the bottom 40% of households by income; Ayushman card required | BPL families in Telangana with a registered Aarogyasri card | AP residents holding a White or Pink ration card | Central govt employees and pensioners (CGHS); retired defence personnel and dependants (ECHS) |
| Annual ceiling | ₹5 lakh per family per year | Procedure-package based; no single annual cap | Enhanced ceiling for life-threatening conditions including cancer; confirm current amount with the scheme | No fixed ceiling; approval-based per treatment course |
| Covers enzalutamide | Covered if on the current oncology package list at an empanelled hospital — confirm before starting | Covered if on the empanelled drug list at your treating hospital — confirm with the scheme | Covered if on the current approved drug list — confirm with your treating centre | Generally reimbursable when prescribed by a recognised specialist with pre-authorisation |
| Key limitation | Oral outpatient drugs have historically had limited coverage; treatment must be at an empanelled hospital | Treatment must be at an Aarogyasri-network hospital; drug list is reviewed periodically | Annual ceiling applies per family across all conditions in that year | Pre-authorisation required before starting; processing time varies |
| How to verify | PM-JAY beneficiary portal or your nearest empanelled hospital's Ayushman desk | Aarogyasri Trust office or the treating hospital's Aarogyasri desk | NTR Trust office or the treating hospital's YSR Aarogyasri desk | Your CGHS wellness centre or nearest ECHS polyclinic |
What do I do if my scheme says no or takes too long?
I have a PM-JAY card but the hospital says enzalutamide is not covered. What should I do?
PM-JAY covers treatments through defined packages updated periodically by the National Health Authority, and enzalutamide may or may not be on the current list at your specific empanelled hospital. Ask whether a different empanelled hospital in your city has it listed, or whether your oncologist can submit a request through the scheme's clinical review process. In parallel, ask your treating team about the manufacturer's patient assistance programme, which exists precisely for situations like this.
What is the manufacturer's patient assistance programme and how do I access it?
Astellas, which makes enzalutamide (Xtandi), runs a patient support programme for those who meet its income and clinical criteria. Your oncologist or the hospital's medical social worker is the right first contact — they can confirm whether the programme is currently active, what income documentation you need, and how to submit the application. The clinical criteria matter as much as the financial ones, so do not apply independently without involving your treating team.
My private insurance has a cancer policy — does it cover oral tablets taken at home?
Many older private policies cover inpatient cancer treatment only, which means an oral medicine taken at home may fall outside the policy's definition of a covered event. Newer policies and cancer-specific riders increasingly include outpatient oral chemotherapy and targeted therapy, but wording varies widely between insurers. Read the sections headed 'oral chemotherapy', 'domiciliary treatment' or 'outpatient expenses' in your policy document. If the wording is ambiguous, submit a pre-authorisation request in writing before starting — a written denial gives you grounds to appeal to the insurer and, if needed, to the IRDAI Insurance Ombudsman.
Can I use more than one scheme at the same time?
In principle, a primary scheme pays first and a secondary scheme may cover what the first does not, up to your actual cost. In practice, coordinating two government schemes, or a government scheme with a private policy, requires the hospital's billing team to manage both claims carefully. Ask the hospital's insurance desk early — some hospitals have experience with this and some do not. Claiming more than your actual cost is not permitted, so keep every receipt and let the hospital guide the process.
The pre-authorisation is taking too long and treatment is urgent. What can I do?
Starting treatment before pre-authorisation is approved creates a serious risk that the full claim will be rejected. If the delay is clinically urgent, your oncologist can write directly to the scheme to request emergency authorisation — CGHS has a specific provision for this. For Aarogyasri and PM-JAY, ask the hospital's scheme desk whether an urgent clinical request has been submitted on your behalf. Document every step in writing: dates of application, letters sent, and responses received. This record becomes your evidence if you need to appeal.
Did you know?
ASCO and ESMO have both documented that oral cancer drugs face disproportionate coverage gaps in health systems worldwide — not because they are less effective, but because most coverage frameworks were designed around inpatient, intravenous treatment.
This means patients on an oral medicine like enzalutamide often need to navigate a less familiar approval pathway than patients receiving IV chemotherapy at the same centre.
Source: ASCO and ESMO policy positions on oral parity in oncology coverage
Explore 50 more Prostate Cancer Targeted Medicines topics
Drug Deep Dive: Enzalutamide (Xtandi)
- Diet and Nutrition While on Enzalutamide
- Dizziness, Falls and Seizure Risk on Enzalutamide
- Does Enzalutamide Need a Steroid? Why It Differs From Abiraterone
- Enzalutamide (Xtandi, Bdenza, Enzamide): The Complete Patient Guide
- Enzalutamide Interactions: Blood Thinners, Statins and Seizure-Threshold Drugs
- Enzalutamide Myths: 'It's Chemotherapy', Fatigue and Loss of Masculinity
- Enzalutamide Price in India: Brand, Generic and Monthly Cost
- Enzalutamide Side Effects: The Complete List and Timeline
- Enzalutamide Success Rate and Survival: An Honest Look at the Numbers
- Enzalutamide With ADT and Other Prostate Cancer Treatments
- Enzalutamide in Elderly Patients and Those With Other Illnesses
- Enzalutamide in Non-Metastatic vs Metastatic Prostate Cancer
- Enzalutamide vs Abiraterone vs Apalutamide: Choosing an AR Inhibitor
- Fertility, Pregnancy and Contraception on Enzalutamide
- How Does Enzalutamide Work? The Androgen Receptor Signalling Inhibitor Explained
- How Long Does Enzalutamide Take to Work?
- How Long Will You Stay on Enzalutamide?
- Memory, Concentration and Blood Pressure Changes on Enzalutamide
- Severe Fatigue on Enzalutamide: The Commonest Reason Men Stop
- Taking Enzalutamide: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Enzalutamide
- When Enzalutamide Stops Working: Resistance and What Comes Next
- Who Is Eligible for Enzalutamide? Advanced and Metastatic Prostate Cancer
- Will Insurance or a Government Scheme Pay for Enzalutamide?
- Work, Travel and Daily Life on Enzalutamide
Drug Deep Dive: Abiraterone (Zytiga)
- Abiraterone (Zytiga, Abirapro, Abretone): The Complete Patient Guide
- Abiraterone Interactions: Steroids, BP Medicines and Herbal Products
- Abiraterone Myths: Steroids, Weight Gain and 'It Stops Working Fast'
- Abiraterone Price in India: Brand, Generic and Monthly Cost
- Abiraterone Side Effects: The Complete List and Timeline
- Abiraterone Success Rate and Survival: An Honest Look at the Numbers
- Abiraterone With ADT, Docetaxel and Radiation: Your Full Regimen Explained
- Abiraterone in Elderly Patients and Those With Other Illnesses
- Abiraterone in Hormone-Sensitive vs Castration-Resistant Prostate Cancer
- Abiraterone vs Enzalutamide: How to Choose in Prostate Cancer
- Diet and Nutrition While on Abiraterone
- Fatigue, Hot Flushes and Joint Pain on Abiraterone
- Fertility, Pregnancy and Contraception on Abiraterone
- How Does Abiraterone Work? The CYP17 Inhibitor Explained
- How Long Does Abiraterone Take to Work?
- How Long Will You Stay on Abiraterone?
- Liver Enzyme Rises on Abiraterone: Why the First Three Months Matter Most
- Swelling, Low Potassium and High Blood Pressure on Abiraterone
- Tests and Monitoring While You Are on Abiraterone
- When Abiraterone Stops Working: Resistance and What Comes Next
- Who Is Eligible for Abiraterone? Advanced and Metastatic Prostate Cancer
- Why Abiraterone Is Always Given With Prednisolone
- Why Abiraterone Must Be Taken on an Empty Stomach
- Will Insurance or a Government Scheme Pay for Abiraterone?
- Work, Travel and Daily Life on Abiraterone
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Does PM-JAY cover enzalutamide?
PM-JAY covers treatments through defined packages updated by the National Health Authority, and whether enzalutamide is on the current package list at your hospital is something to confirm at the hospital's Ayushman Bharat desk before you start. Use the PM-JAY beneficiary portal with your Aadhaar to check which hospitals near you are empanelled and what their current cancer packages cover. Package lists are updated periodically, so the position may have changed since you last looked.
What documents do I need to apply for scheme coverage?
The exact list varies by scheme, but most require the scheme card or eligibility certificate, a copy of your Aadhaar, the oncologist's prescription naming enzalutamide with diagnosis and stage, recent investigation reports confirming the diagnosis, and a cost estimate from the hospital or pharmacy. For CGHS, you may also need a referral letter from your wellness centre if you are being treated at a private empanelled hospital. Collect everything before submitting the pre-authorisation application — an incomplete submission adds weeks to the process.
I do not qualify for any scheme and cannot afford the full cost. What else can I do?
Three routes are worth pursuing in parallel. First, ask your oncologist whether the Astellas patient assistance programme applies to your income and clinical situation — the hospital's medical social worker can help with the application. Second, ask whether any open clinical trials at your centre include enzalutamide, because trial participants receive the study drug without charge. Third, ask your oncologist whether CDSCO-approved generic versions of enzalutamide are available and clinically appropriate for your case. A combination of these routes may make treatment achievable.
My private insurance rejected my enzalutamide claim. Can I appeal?
Yes. You are entitled to a formal appeal through the insurer, and if that does not succeed, through the IRDAI Insurance Ombudsman in your region. For the appeal, your oncologist should provide a letter explaining why enzalutamide is the indicated treatment for your specific diagnosis and why the policy wording supports the claim. Keep copies of every document submitted. Many initial rejections for oral cancer drugs are overturned on appeal when clear clinical justification is provided. The IRDAI Ombudsman service is free and does not require a lawyer.
How does CGHS handle enzalutamide — is there an approved list?
CGHS reimburses medicines prescribed by a recognised specialist for a condition where the drug is clinically indicated. Approval is not automatic — you or your hospital must apply for pre-authorisation before starting, with the oncologist's prescription and supporting documents. CGHS does not publish a single static approved drug list; decisions are made case by case based on the prescription and clinical justification. If the situation is urgent, your oncologist can write a clinical urgency letter requesting faster processing.
Will my ESI coverage help with enzalutamide?
ESI provides access to medicines through its own hospitals and dispensaries, and beneficiaries can be referred to specialist cancer care when the ESI network cannot provide it directly. Whether enzalutamide is dispensed through the ESI system, or reimbursed for a referred patient, depends on the regional ESI office and the arrangement with your treating hospital. Ask your employer's HR team which ESI dispensary you are registered to, then ask that dispensary whether a specialist referral and drug reimbursement pathway exists. The answer varies between states.